Back to company

Nectar RHS Komplementar ApS: Financial statements 2025

CVR: 41934530

Nectar RHS Komplementar ApS (CVR 41934530) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 38,849 compared with DKK 58,075 the year before. Equity amounted to DKK 177,416. The solvency ratio was 82.3%. The company had 1 employee in the financial year.

Gross Profit
-5,000 kr.
Profit/Loss
38,849 kr.
Equity
177,416 kr.
Total Assets
215,688 kr.
Employees
1

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025--5 t.39 t.177 t.1
2024--5 t.58 t.139 t.1
2023--5 t.15 t.80 t.1
2022--13 t.10 t.65 t.0
2021--5 t.16 t.56 t.0

Official annual report

View the official annual report directly on the page with a Pro subscription.

Find more companies like Nectar RHS Komplementar ApS

Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.

Try the lead list generator

Events in 2025

Nectar RHS Komplementar ApS: The 2024 annual report is outMay 7, 2025

Nectar RHS Komplementar ApS has published its annual report for 2024. Gross profit came to DKK -5,000, and the net result was DKK 58,075.

About Nectar RHS Komplementar ApS

Nectar RHS Komplementar ApS is a Danish company of the type Anpartsselskab based in København K, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Bjørk Krogshave. The company is owned by PharmaService I/S and Nectar Invest A/S. In 2025, the company reported a gross profit of DKK -5,000 and a net result of DKK 38,849 compared with DKK 58,075 the year before. Equity amounted to DKK 177,416.

Other financial years